Zheng A, Fox MP, Greener R, Kileel EM, et al. Initiation of Dolutegravir vs Efavirenz on Viral Suppression and Retention at 6-months: A Regression Discontinuity Design. J Acquir Immune Defic Syndr 2025 Feb 6. doi: 10.1097/QAI.0000000000003642.
PMID: 39913899